BioSpace News Archive

Deals

Turning Point Therapeutics Announces Pricing of Initial Public Offering

Turning Point Therapeutics, Inc. announced the pricing of its initial public offering of 9,250,000 shares of its common stock at a price to the public of $18.00 per share.

April 16, 2019
·
3 min read
Deals

INVO Bioscience Reports Record Fourth Quarter and Year End 2018 Financial Results

INVO Bioscience, Inc. announced its fourth quarter and year end financial results for the periods ended December 31, 2018 as well as recent highlights.

April 16, 2019
·
8 min read
Deals

PDL BioPharma to Hold Annual Meeting of Stockholders on June 20, 2019

PDL BioPharma, Inc. announced that the Company will hold its annual meeting of stockholders on Thursday, June 20, 2019, at 3:00 p.m. Pacific Time for all stockholders of record on April 26, 2019.

April 16, 2019
·
1 min read
Business

Silence Therapeutics Announces Board Change

The Company’s previously announced process to appoint a new Chair is ongoing.

April 16, 2019
·
1 min read
Surge of Indian biosimilars market forecast in 2019

CPhI data predicts India to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production

April 16, 2019
·
5 min read
Centrelake Medical Group, Inc. Provides Notice Of Data Incident

Centrelake Medical Group, Inc. is taking action after it recently became aware that there was an incident in which an unknown third party may have gained access to the data in its practice.

April 16, 2019
·
3 min read
Deals

ZGNX CLASS ACTION ALERT: Hagens Berman Alerts Zogenix (ZGNX) Investors to Securities Class Action, Encourages Investors to Contact the Firm

Hagens Berman Sobol Shapiro LLP alerts investors in Zogenix, Inc. to the securities class action pending in the United States District Court for the Northern District of California and to the June 11, 2019 Lead Plaintiff deadline.

April 16, 2019
·
2 min read